Drawing for CYSTOLAMINE

USPTO serial 78281861

CYSTOLAMINE

Reviewed by CopyMark Law Group

Reg. 2877507Status 710
Filing date
Status date
Registration date
Aug 24, 2004
Examiner
VOGLER, ANN LINNEHAN
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CYSTOLAMINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Veterinary pharmaceutical preparations for use in the treatment and management of canine urinary incontinenceSECTION 8 - CANCELLEDOct 21, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2025CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Aug 24, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 7, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 15, 2014NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
May 15, 2014RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
May 15, 201489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
May 15, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 2, 201489AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
May 2, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 2, 2014E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 8, 2010C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 8, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 26, 2010E815TEAS SECTION 8 & 15 RECEIVED—
Aug 24, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 1, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 12, 2004NPUBNOTICE OF PUBLICATION—
Mar 25, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 1, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 1, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2004GNSLLETTER OF SUSPENSION E-MAILED—
Feb 10, 2004DOCKASSIGNED TO EXAMINER—
Dec 15, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—

Frequently asked questions

Related guidance